Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of `window-phase' blood donations

Authors: Lee, S. R.; Peterson, J.1; Niven, P.1; Bahl, C.1; Page, E.1; DeLeys, R.1; Giordano-Schmidt, D.1; Baggett, D.1; Green, G.1

Source: Vox Sanguinis, Volume 80, Number 1, January 2001 , pp. 19-23(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background and Objectives

Recent studies have suggested that potentially infectious donations provided during the antibody-negative `window' phase of hepatitis C virus (HCV) infection may be identified by testing for viral RNA or HCV core protein. We therefore evaluated the performance of an HCV antigen enzyme-linked immunosorbent assay (ELISA) for identification of window-phase donations and for prospective screening of blood donors. Materials and Methods

One-hundred and twenty-eight archived plasma donations containing HCV RNA, but lacking antibody to HCV (anti-HCV), were tested by using the HCV antigen ELISA, together with 9951 freshly collected serum and plasma specimens from blood donors. Results

HCV core antigen was detected in 94% (120/128) of window-phase plasma donations. Overall specificity in freshly collected blood donor specimens was 99·74%. Two putative window-phase donations containing HCV core protein and viral RNA were identified from paid plasma donors by prospective testing with the HCV antigen ELISA. Conclusion

These results indicate that an HCV antigen ELISA can identify almost all (94%) of viraemic donations given during the seronegative window phase of infection. The performance of the HCV antigen ELISA appears to be suitable for large-scale screening of blood donations.

Keywords: blood donors; enzyme-linked immunosorbent assay (ELISA); HCV antigen; hepatitis C virus (HCV), window phase; viral RNA

Document Type: Research article

DOI: 10.1046/j.1423-0410.2001.00008.x

Affiliations: 1: Ortho Clinical Diagnostics, Raritan, NJ, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$46.48 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A